Rahim, F.; Ullah, H.; Taha, M.; Hussain, R.; Sarfraz, M.; Iqbal, R.; Iqbal, N.; Khan, S.; Ali Shah, S.A.; Albalawi, M.A.;
et al. Synthesis of New Triazole-Based Thiosemicarbazone Derivatives as Anti-Alzheimer’s Disease Candidates: Evidence-Based In Vitro Study. Molecules 2023, 28, 21.
https://doi.org/10.3390/molecules28010021
AMA Style
Rahim F, Ullah H, Taha M, Hussain R, Sarfraz M, Iqbal R, Iqbal N, Khan S, Ali Shah SA, Albalawi MA,
et al. Synthesis of New Triazole-Based Thiosemicarbazone Derivatives as Anti-Alzheimer’s Disease Candidates: Evidence-Based In Vitro Study. Molecules. 2023; 28(1):21.
https://doi.org/10.3390/molecules28010021
Chicago/Turabian Style
Rahim, Fazal, Hayat Ullah, Muhammad Taha, Rafaqat Hussain, Maliha Sarfraz, Rashid Iqbal, Naveed Iqbal, Shoaib Khan, Syed Adnan Ali Shah, Marzough Aziz Albalawi,
and et al. 2023. "Synthesis of New Triazole-Based Thiosemicarbazone Derivatives as Anti-Alzheimer’s Disease Candidates: Evidence-Based In Vitro Study" Molecules 28, no. 1: 21.
https://doi.org/10.3390/molecules28010021
APA Style
Rahim, F., Ullah, H., Taha, M., Hussain, R., Sarfraz, M., Iqbal, R., Iqbal, N., Khan, S., Ali Shah, S. A., Albalawi, M. A., Abdelaziz, M. A., Alatawi, F. S., Alasmari, A., Sakran, M. I., Zidan, N., Jafri, I., & Khan, K. M.
(2023). Synthesis of New Triazole-Based Thiosemicarbazone Derivatives as Anti-Alzheimer’s Disease Candidates: Evidence-Based In Vitro Study. Molecules, 28(1), 21.
https://doi.org/10.3390/molecules28010021